Buscar

01/05/2025 Oral mucosal papules in an immunosuppressed girl
Peirano, F, Rusiñol, L, Iznardo, H, Carmona-Rocha, E, Puig, L, Roé, E. Oral mucosal papules in an immunosuppressed girl. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2025; 50(5)DOI:10.1093/ced/llaf007. PMID:39775820. IF:2.800(Q2/4D).
01/05/2025 Multicenter, Prospective, Case-Control Study of Exposome in Melanoma
Navarro-Bielsa, A, Gracia-Cazaña, T, Almagro, M, De-la-Fuente-Meira, S, Florez, A, Yélamos, O, Montero-Vilchez, T, González-Cruz, C, Diago, A, Abadías-Granado, I, Fuentelsaz, V, Colmenero, M, Bañuls, J, Arias-Santiago, S, Buendía-Eisman, A, Almenara-Blasco, M, Gil-Pallares, P, Gilaberte, Y. Multicenter, Prospective, Case-Control Study of Exposome in Melanoma. Actas Dermo-Sifiliograficas. 2025; 116(5)DOI:10.1016/j.ad.2024.09.022. PMID:39756676. IF:(Q/D).
01/04/2025 Histological deep margins in cutaneous squamous cell carcinoma of the scalp and risk of recurrence
Verdaguer-Faja, J, Guerra-Amor, A, Ferrándiz-Pulido, C, Abril-Pérez, C, Estrada, RB, Masferrer, E, Lopez-Castillo, D, Deza, G, Leal, L, Marti-Marti, I, Ruiz-Salas, V, Yébenes, M, Martin, LM, Baliu, C, Castany, A, Boada, A, Toll, A, Jaka, A. Histological deep margins in cutaneous squamous cell carcinoma of the scalp and risk of recurrence. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(4)DOI:10.1111/jdv.20250. PMID:39036869. IF:8.000(Q1/1D).
01/04/2025 Parental Assessment of Infantile Hemangioma Cosmetic Clinical Outcomes: Results of the Spanish Hemangioma Nationwide Prospective Cohort
Colmenero-Sendra, M, del Boz-González, J, Torres, EB, Bernabéu-Wittel, J, Roé-Crespo, E, Vicente, A, Valdivieso-Ramos, M, Martín-Santiago, A, Palencia-Pérez, SI, Montserrat-García, MT, Azón-Masoliver, A, Dañino, M, Prims, CT, Prat, C, Giacaman, A, Domínguez-Cruz, JJ, Alonso, AB, Grau-Pérez, M, Descalzo, MA, García-Doval, I. Parental Assessment of Infantile Hemangioma Cosmetic Clinical Outcomes: Results of the Spanish Hemangioma Nationwide Prospective Cohort. Actas Dermo-Sifiliograficas. 2025; 116(4)DOI:10.1016/j.ad.2024.06.010. PMID:39032773. IF:(Q/D).
01/03/2025 The impact on pain and mental health in patients with hidradenitis suppurativa: Results from the HS Uncovered global patient survey
Kokolakis, G, Guillem, P, Vilarrasa, E, Alarcon, I, Go, M, Newbold, G, Mamareli, A, Richardson, C, McGrath, B, Kirby, JS. The impact on pain and mental health in patients with hidradenitis suppurativa: Results from the HS Uncovered global patient survey. EXPERIMENTAL DERMATOLOGY. 2025; 34DOI:. PMID:. IF:3.100(Q2/3D).
01/03/2025 Lymphedema in hidradenitis suppurativa: A multicenter case series
Garbayo-Salmons, P, Vilarrasa, E, Haselgruber, S, Gamissans, M, Ciudad, C, Martorell, A, Aguayo-Ortiz, RS, Romani, J, Fornons-Servent, R, Molina-Leyva, A. Lymphedema in hidradenitis suppurativa: A multicenter case series. EXPERIMENTAL DERMATOLOGY. 2025; 34DOI:. PMID:. IF:3.100(Q2/3D).
01/03/2025 Major predictors of remission in hidradenitis suppurativa: An 8-year survival study with adalimumab
Vilarrasa, E, Salmons, PG, Bassas-Vila, J, Mora, V, Fuertes, I, Luque, M, Fornons-Servent, R, Martin, G, Aguayo-Ortiz, RS, Ceravalls, J, Mollet, J, Gómez, A, Masferrer, E, Corral, O, Matas, C, Romaní, J. Major predictors of remission in hidradenitis suppurativa: An 8-year survival study with adalimumab. EXPERIMENTAL DERMATOLOGY. 2025; 34DOI:. PMID:. IF:3.100(Q2/3D).
01/03/2025 Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
Silverberg, JI, Bieber, T, Paller, AS, Beck, L, Kamata, M, Puig, L, Wiseman, M, Ezzedine, K, Irvine, AD, Foley, P, Del Rosso, J, Gold, LS, Johansson, E, Dossenbach, M, Gallo, G, Akmaz, B, Casillas, M, Karlsson, A, Curteis, T, Chovatiya, R. Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy. Dermatology and Therapy. 2025; 15(3)DOI:10.1007/s13555-025-01357-7. PMID:39953372. IF:4.200(Q1/1D).
01/03/2025 Bimekizumab demonstrates effective responses and safety in hidradenitis suppurativa: Short-term real-world observational multicentric study from Spain
Mansilla-Polo, M, Benvant, MP, Fernández-Crehuet, P, Vilarrasa, E, Albanell-Fernández, C, Morales-Tedone, E, Rausell-Félix, F, Alcalá-García, R, Matellanes-Palacios, M, Martín-Ezquerra, G, Alfageme, F, Blanco, CC, López-Villaescusa, MT, Salmons, PG, Martorell, A, Muñoz, BE, Navarro-Blanco, F, Torregrosa, DM, Barrales, CC, Leyva, AM, Botella-Estrada, R. Bimekizumab demonstrates effective responses and safety in hidradenitis suppurativa: Short-term real-world observational multicentric study from Spain. EXPERIMENTAL DERMATOLOGY. 2025; 34DOI:. PMID:. IF:3.100(Q2/3D).
01/03/2025 Advanced Doppler Ultrasound Insights: A Multicenter Prospective Study on Healthy Skin
Giavedoni, P, Romaní, J, de Cabo, F, García-Martínez, FJ, Quintana-Codina, M, Roè-Crespo, E, de Vega, IF, Soria-Gili, X, Aguayo-Ortiz, R, Garbayo-Salmons, P, Castillo, G, Vidal-Sarró, D, Mollet, J, Serra, L, Gonzalez, C, López-Trujillo, E, Just, M, Combalia, M, Podlipnik, S, Malvehy, J, Wortsman, X. Advanced Doppler Ultrasound Insights: A Multicenter Prospective Study on Healthy Skin. Diagnostics. 2025; 15(5)DOI:10.3390/diagnostics15050569. PMID:40075816. IF:3.300(Q1/2D).
10/02/2025 Global Delphi consensus on treatment goals for generalized pustular psoriasis
Barker, JN, Casanova, E, Choon, SE, Foley, P, Fujita, H, Gonzalez, C, Gooderham, M, Marrakchi, S, Puig, L, Romiti, R, Thaçi, D, Zheng, M, Strober, B. Global Delphi consensus on treatment goals for generalized pustular psoriasis. BRITISH JOURNAL OF DERMATOLOGY. 2025; 192(4)DOI:10.1093/bjd/ljae491. PMID:39844356. IF:9.600(Q1/1D).
03/02/2025 Postswitching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases
Puig, L. Postswitching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases. BRITISH JOURNAL OF DERMATOLOGY. 2025; 192(4)DOI:10.1093/bjd/ljaf003. PMID:39761694. IF:9.600(Q1/1D).
01/02/2025 Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023
Pesqué, D, Planella-Fontanillas, N, Borrego, L, Sanz-Sánchez, T, Zaragoza-Ninet, V, Serra-Baldrich, E, Miquel-Miquel, FJ, Silvestre-Salvador, JF, Córdoba-Guijarro, S, Sánchez-Gilo, A, Mercader-García, P, Navarro-Triviño, FJ, Ortiz-de-Frutos, FJ, Tous-Romero, F, Rodríguez-Serna, M, Melé-Ninot, G, Barrabés-Torrella, C, Ruiz-González, I, Pastor-Nieto, MA, Carrascosa-Carrillo, JM, Gómez-de-la-Fuente, E, Sánchez-Pedreño-Guillén, P, Sánchez-Pérez, J, Pereyra-Rodríguez, JJ, Gatica-Ortega, ME, González-Pérez, R, Pujol, RM, Descalzo, MAG, García-Doval, I, Giménez-Arnau, AM. Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023. CONTACT DERMATITIS. 2025; 92(2)DOI:10.1111/cod.14702. PMID:39394969. IF:4.600(Q1/1D).
01/02/2025 Refractory Lichen Sclerosus Treated With Fractional CO2 Laser-assisted Drug Delivery Photodynamic Therapy Using 5-Aminolevulinic Acid: A Case Series
Mateu-Arrom, L, Yélamos, O, Morales-Munera, CE. Refractory Lichen Sclerosus Treated With Fractional CO2 Laser-assisted Drug Delivery Photodynamic Therapy Using 5-Aminolevulinic Acid: A Case Series. Actas Dermo-Sifiliograficas. 2025; 116(2)DOI:10.1016/j.ad.2024.09.017. PMID:39419378. IF:(Q/D).
01/02/2025 AEDV Expert Document on the Management of Ulcerative Venereal Infections
Morales-Múnera, CE, Montoya, F, de Loredo, N, Sendagorta, E. AEDV Expert Document on the Management of Ulcerative Venereal Infections. Actas Dermo-Sifiliograficas. 2025; 116(2)DOI:10.1016/j.ad.2024.11.012. PMID:39566736. IF:(Q/D).
01/02/2025 Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study
Martorell-Calatayud, A, Santos-Alarcón, S, Sahuquillo-Torralba, A, Rivera-Díaz, R, Belinchón-Romero, I, Ruiz-Genao, D, Romero-Maté, A, Ruiz-Villaverde, R, Ferran-Farrés, M, Gallardo-Hernández, F, Almenara-Blasco, M, Suarez-Perez, JA, González-Cantero, A, Martínez-Lorenzo, E, Fernández-Armenteros, JM, del Alcázar-Viladomiu, E, García-Latasa, J, Rocamora-Durant, V, Ara-Martín, M, Mateu-Puchades, A, Llamas-Velasco, M, Vilarrasa, E, Velasco-Pastor, M, De la Cueva, P, Carrascosa, JM, Magdaleno-Tapial, J. Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study. Actas Dermo-Sifiliograficas. 2025; 116(2)DOI:10.1016/j.ad.2024.02.030. PMID:38452889. IF:(Q/D).
01/01/2025 Cyclosporine for the treatment of chronic spontaneous urticaria refractory to antihistamines and omalizumab: a case series
Mateu-Arrom, L, Giménez-Arnau, AM, Expósito-Serrano, V, Bonfill-Orti, M, Serra-Baldrich, E, Yélamos, O, Spertino, J. Cyclosporine for the treatment of chronic spontaneous urticaria refractory to antihistamines and omalizumab: a case series. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2025; 64(1)DOI:10.1111/ijd.17358. PMID:38940007. IF:3.200(Q1/3D).
01/01/2025 Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis
Cerezuela-Fuentes, P, Gonzalez-Cao, M, Puertolas, T, Manzano, JL, Maldonado, C, Yelamos, O, Berciano-Guerrero, MA, Martin-Liberal, J, Muñoz-Couselo, E, Espinosa, E, Drozdowskyj, A, Berrocal, A, Soria, A, Marquez-Rodas, I, Martin-Algarra, S, Quindos, M, Puig, S. Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis. Clinical & Translational Oncology. 2025; 27(1)DOI:10.1007/s12094-024-03583-5. PMID:38951438. IF:2.500(Q3/6D).
01/01/2025 Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus
Torres, T, Brembilla, NC, Langley, RG, Warren, RB, Thaci, D, Kolios, AGA, Prinz, JC, Londono-Garcia, A, Nast, A, Santin, M, Goletti, D, Abreu, M, Spuls, P, Boehncke, WH, Puig, L. Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(1)DOI:10.1111/jdv.20287. PMID:39149807. IF:8.000(Q1/1D).
01/01/2025 Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology
Carmona-Rocha, E, Rusiñol, L, Puig, L. Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology. Pharmaceutics. 2025; 17(1)DOI:10.3390/pharmaceutics17010091. PMID:39861739. IF:5.500(Q1/1D).